Overview

Combination Chemotherapy as First-Line Therapy in Treating Patients With Stage IV Gastric Cancer That Cannot Be Removed By Surgery

Status:
Terminated

Trial end date:
2010-03-01

Target enrollment:

Participant gender:

Summary

RATIONALE: Drugs used in chemotherapy, such as floxuridine, leucovorin, oxaliplatin, and docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells. PURPOSE: This phase II trial is studying how well combination chemotherapy works as first-line therapy in treating patients with stage IV gastric cancer that cannot be removed by surgery.

Phase:

Phase 2

Details

Lead Sponsor:

University of Miami
University of Miami Sylvester Comprehensive Cancer Center

Treatments:

Docetaxel
Floxuridine
Leucovorin
Levoleucovorin
Oxaliplatin